Cargando…
Perampanel’s forgiveness factor in a variable medication adherence paradigm in a rat model of chronic epilepsy
BACKGROUND: Poor medication adherence contributes to increased morbidity and mortality in patients with epilepsy and may be under-addressed in clinical practice. Ethical concerns make it impossible to study the impact of medication nonadherence in clinical trials, but our previous work emphasizes th...
Autores principales: | Guignet, Michelle, Campbell, Amanda, Vuong, Jonathan, Whittington, Dale, White, H. Steve |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510183/ https://www.ncbi.nlm.nih.gov/pubmed/37730661 http://dx.doi.org/10.1186/s12967-023-04490-z |
Ejemplares similares
-
Forgiveness of INSTI-Containing Regimens at Drug Concentrations Simulating Variable Adherence In Vitro
por: Acosta, Rima K., et al.
Publicado: (2022) -
888. In Vitro Forgiveness of INSTI-Containing Regimens at Drug Concentrations Simulating Variable Adherence
por: Acosta, Rima K, et al.
Publicado: (2021) -
Perampanel in lissencephaly-associated epilepsy
por: Ikemoto, Satoru, et al.
Publicado: (2019) -
Allopregnanolone and perampanel as adjuncts to midazolam for treating diisopropylfluorophosphate‐induced status epilepticus in rats
por: Dhir, Ashish, et al.
Publicado: (2020) -
Adjunctive perampanel for glioma-associated epilepsy()
por: Dunn-Pirio, Anastasie M., et al.
Publicado: (2018)